Asenapine Transdermal Patch and Morphine: Interaction Details
- Morphine
- Arymo ERKadianMorphabond +11 more
- Asenapine Transdermal Patch
- SecuadoSaphris
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Asenapine Transdermal Patch and Morphine interaction:
Morphine
- Arymo ER
- Kadian
- Morphabond
- MS Contin
- Avinza
- Oramorph SR
- Roxanol-T
- Infumorph
- Mitigo
- Duramorph
- Opium Tincture Deodorized
- Infumorph 200
- Infumorph 500
- Opium
Asenapine Transdermal Patch
- Secuado
- Saphris
What Happens When You Take Asenapine Transdermal Patch With Morphine
What can happen when they are taken together (rated Major)
Increased risk of profound , , , coma and death
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Combining morphine with depressants should be limited to patients for whom other treatment options are insufficient. When the two must be given together, keep both the dose and the duration to the minimum required.
A reduced dose of either morphine or the CNS depressant may be considered, with careful monitoring for respiratory depression and sedation.234 When starting the morphine/naltrexone combination, begin with one-third to one-half of the standard morphine/naltrexone dose.5
When starting Morphabond ER(TM), use the lowest available dose of 15 mg every 12 hours, and consider lowering the dosage of the coadministered CNS depressant.6 Taking morphine at the same time as CNS depressants raises the risk of overdose, so prescribing naloxone for emergency treatment of opioid overdose should be considered.7
The Asenapine Transdermal Patch and Morphine Interaction, Explained
Morphine is a strong pain medicine, and the asenapine patch (Secuado) treats conditions like schizophrenia. Both can make you drowsy and slow down your brain, so together the effect can add up. This can cause heavy sleepiness, slow or shallow breathing, dizziness or low blood pressure (especially when standing up), and in rare serious cases, passing out or worse.
The good news is your care team can manage this. They may use lower doses and keep a closer eye on you. Keep taking your medicines as prescribed, and talk with your pharmacist or doctor about any questions. Ask whether having naloxone at home makes sense for you.
Mechanism: , ( agonism plus sedating effects of asenapine, including H1 and alpha-1 ). Increases risk of profound , , , coma, and death. No major PK interaction is implicated. Onset unspecified; evidence probable; severity major.
- Reserve for patients in whom alternatives are inadequate; use lowest effective doses and shortest duration.
- Consider dose reduction of morphine or asenapine; closely monitor for sedation, respiratory depression, and hypotension.
- Morphine/naltrexone initiation: start at one-third to one-half of usual dose. Morphabond ER initiation: start at 15 mg every 12 hours and consider lowering the depressant dose.
- Consider prescribing naloxone for emergency treatment of opioid overdose.
See the 7 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Asenapine Transdermal Patch and Morphine Interact
The likely mechanism
effects
How to Manage the Asenapine Transdermal Patch and Morphine Interaction
Your care team usually only combines these medicines when other options are not a good fit. When they are used together, your team typically:
- Uses the lowest dose for the shortest time needed, with doses adjusted and individualized for you.
- Monitors you more closely for sleepiness and slowed breathing.
- May prescribe naloxone to keep on hand for emergencies.
What you can do: keep taking both as prescribed. Tell your pharmacist or prescriber if you feel unusually drowsy, confused, or dizzy. Anyone around you should get emergency help if your breathing becomes slow or shallow or you are hard to wake.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Asenapine Transdermal Patch or Morphine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
3 reports from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Drug Safety Communications: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning
One study found that the rate of emergency department visits related to nonmedical use and involving both analgesics and rose significantly from 11 to 34.2 per 100,000 over the period from 2004 to 2011. Over the same period, drug overdose deaths attributed to prescribed and greater than prescribed doses of the two drug classes also rose significantly, from 0.6 to 1.7 per 100,000, and the proportion of overdose deaths attributed to benzodiazepines rose significantly from 18% to 31%.1
-
Report 2 · Study title
Drug Safety Communications: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning
A prospective cohort study reported that the overdose death rate associated with dispensing of both analgesics and was 10 times greater than that associated with dispensing of opioid analgesics alone (7 vs 0.7 per 10,000 person years).1
-
Report 3 · Study title
Drug Safety Communications: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning
A cohort study using data from 2004 to 2009 compared patients taking analgesics with and without prescriptions. Relative to patients taking opioid analgesics with no history of a benzodiazepine prescription, the risk of fatal overdose was significantly elevated by 2.33 fold in those with a history of a benzodiazepine prescription and by 3.86 fold in those with a current benzodiazepine prescription. The risk of drug overdose death rose as the daily dose of benzodiazepines increased.1
Asenapine Transdermal Patch and Morphine: Common Questions
How serious is the Asenapine Transdermal Patch and Morphine interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Asenapine Transdermal Patch and Morphine interaction managed?
Your care team usually only combines these medicines when other options are not a good fit. When they are used together, your team typically: Uses the lowest dose for the shortest time needed, with doses adjusted and individualized for you. Monitors you more closely for sleepiness and slowed breathing. May prescribe naloxone to keep on hand for emergencies. What you can do: keep taking both as pre… Management is individual — always follow your own care team's guidance.
Is there an alternative to taking Asenapine Transdermal Patch with Morphine?
The interaction record says a different medicine may be considered in place of one of these two.
Only your prescriber can decide whether a change fits you, so talk with them before changing either medicine.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Ask About the Asenapine Transdermal Patch and Morphine Interaction
Ask in your own words about taking Asenapine Transdermal Patch and Morphine together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (7)
- US Food and Drug Administration (FDA): Drug Safety Communications: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning. US Food and Drug Administration (FDA). Silver Spring, MD. 2016.
- Product Information: ARYMO(TM) ER oral extended-release tablets, morphine sulfate oral extended-release tablets. Egalet US Inc (per manufacturer), Wayne, PA, 2017. DailyMed
- Product Information: KADIAN(R) oral extended-release capsules, morphine sulfate oral extended-release capsules. Allergan USA, Inc (per FDA), Irvine, CA, 2016. DailyMed
- Product Information: DURAMORPH intravenous, epidural, intrathecal injection, morphine sulfate intravenous, epidural, intrathecal injection. Hikma Pharmaceuticals USA Inc (Per FDA), Berkeley, NJ, 2023. DailyMed
- Product Information: EMBEDA(R) oral extended-release capsules, morphine sulfate naltrexone HCl oral extended-release capsules. Pfizer Inc. (per FDA), New York, NY, 2016. DailyMed
- Product Information: MORPHABOND(TM) ER oral extended-release tablets, morphine sulfate oral extended-release tablets. Daiichi Sankyo Inc (per FDA), Basking Ridge, NJ, 2018. DailyMed
- Product Information: MS CONTIN(R) oral extended-release tablets, morphine sulfate oral extended-release tablets. Purdue Pharma LP (per FDA), Stamford, CT, 2023. DailyMed
Other Serious Interactions of Asenapine Transdermal Patch and Morphine
Also serious with Morphine
- Linezolid InjectionContraindicated
- IsocarboxazidContraindicated
- LinezolidContraindicated
- Methylene BlueContraindicated
Also serious with Asenapine Transdermal Patch
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven. This interaction.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.